이비인후과 영역에서의 보툴리눔 독소의 활용

키워드

참고문헌 (71)

1. Erbguth FJ, "F rom p oison t o r emedy : t he c hequered h istory o f botulinum toxin", J Neural Transm(Vienna), 115(4), pp.559~565 (2008)
2. Anandan C, "Botulinum toxin in movement disorders : an update", Toxins(Basel), 13(1), pp.42~ (2021)
3. Scott AB, "Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery", Ophthalmology, 87(10), pp.1044~1049 (1980)
4. Hyodo M, "Botulinum toxin therapy for spasmodic dysphonia in Japan : the history and an update", Toxins(Basel), 14(7), pp.451~ (2022)
5. Strohl MP, "Botulinum toxin for chronic parotid sialadenitis : a case series and systematic review", Laryngoscope Investig Otolaryngol, 6(3), pp.404~413 (2021)
6. Ali MJ, "Botulinum toxin in the treatment of first bite syndrome", Otolaryngol Head Neck Surg, 139(5), pp.742~743 (2008)
7. Rinzin K, "Botulinum toxin for chronic rhinitis : a systematic review and meta-analysis", Int Forum Allergy Rhinol, 11(11), pp.1538~1548 (2021)
8. Park JM, "Intratympanic botulinum toxin injection as a new therapeutic modality for middle ear myoclonic tinnitus", Otolaryngol Head Neck Surg, 169(2), pp.348~357 (2023)
9. Smith TJ, "Historical and current perspectives on Clostridium botulinum diversity", Res Microbiol, 166(4), pp.290~302 (2015)
10. Rho NK, "An update on the cosmetic use of botulinum toxin : the pattern of practice among Korean dermatologists", Toxins(Basel), 14(5), pp.329~ (2022)
11. Ban MJ, "Guidelines for the use of botulinum toxin in otolaryngology from the Korean Society of Laryngology, Phoniatrics and Logopedics guideline task force", Clin Exp Otorhinolaryngol, 16(4), pp.291~307 (2023)
12. Lee SW, "Botulinum toxin for other head and neck lesions", J Korean Soc Laryngol Phoniatr Logop, 23(2), pp.104~110 (2012)
13. Tereshko Y, "Efficacy and safety of two different botulinum toxin type A dilutions in chronic migraineurs", Toxicon, 227, pp.107096~ (2023)
14. Slengerik-Hansen J, "Botulinum toxin treatment of objective tinnitus because of essential palatal tremor : a systematic review", Otol Neurotol, 37(7), pp.820~828 (2016)
15. Lockwood AH, "Tinnitus", N Engl J Med, 347(12), pp.904~910 (2002)
16. Le Pajolec C, "Objective tinnitus and palatal myoclonus. A new therapeutic approach", Ann Otolaryngol Chir Cervicofac, 107(6), pp.363~365 (1990)
17. Slengerik-Hansen J, "Botulinum toxin treatment of objective tinnitus because of essential palatal tremor : a systematic review", Otol Neurotol, 37(7), pp.820~828 (2016)
18. Celik M, "T he development of synkinesis after facial nerve paralysis", Eur Neurol, 43(3), pp.147~151 (2000)
19. Roggenkämper P, "Botulinum toxin treatment of synkinesia following facial paralysis", HNO, 38(8), pp.295~297 (1990)
20. Cooper L, "Botulinum toxin treatment for facial palsy : a systematic review", J Plast Reconstr Aesthet Surg, 70(6), pp.833~841 (2017)
21. de Jongh FW, "Botulinum toxin A treatment in facial palsy synkinesis : a systematic review and meta-analysis", Eur Arch Otorhinolaryngol, 280(4), pp.1581~1592 (2023)
22. Bousquet J, "Allergic rhinitis and its impact on asthma(ARIA)2008", Allergy, 63(Suppl 86), pp.8~160 (2008)
23. Jaradeh SS, "Autonomic nervous system evaluation of patients with vasomotor rhinitis", Laryngoscope, 110(11), pp.1828~1831 (2000)
24. Huang CC, "Comparison between botulinum toxin and steroid septal injection in the treatment of allergic rhinitis", Laryngoscope Investig Otolaryngol, 7(1), pp.12~21 (2022)
25. Ismail M, "Comparing the effects of bot ulinu m toxin-A and multiple su rgical parasympathectomy on treatment of allergic rhinitis", Am J Otolaryngol, 44(4), pp.103893~ (2023)
26. Norton PG, "Snoring in adults : some epidemiologic aspects", Can Med Assoc J, 128(6), pp.674~675 (1983)
27. Kühnel TS, "Treatment of habitual snoring with botulinum toxin : a pilot study", Sleep Breath, 12(1), pp.63~68 (2008)
28. Lee SW, "Clinical application of botulinum toxin to contact granuloma and vocal nodule", J Korean Soc Laryngol Phoniatr Logop, 30(2), pp.82~86 (2019)
29. Troung DD, "Doubleblind controlled study of botulinum toxin in adductor spasmodic dysphonia", Laryngoscope, 101(6 Pt 1), pp.630~634 (1991)
30. Liu Y, "Comparison of the efficacy and adverse effects of unilateral or bilateral botulinum toxin injections for adductor spasmodic dysphonia : a systematic review and meta-analysis", Eur Arch Otorhinolaryngol, 281(3), pp.1357~1369 (2024)
31. Blitzer A, "Botulinum toxin management of spasmodic dysphonia(laryngeal dystonia) : a 12-year experience in more than 900 patients", Laryngoscope, 108(10), pp.1435~1441 (1998)
32. Bielamowicz S, "Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia", Ann Otol Rhinol Laryngol, 110(5 Pt 1), pp.406~412 (2001)
33. Haubenberger D, "Essential tremor", N Engl J Med, 378(19), pp.1802~1810 (2018)
34. Sharma S, "Treatment of essential tremor : current status", Postgrad Med J, 96(1132), pp.84~93 (2020)
35. Hertegård S, "Botulinum toxin injections for essential voice tremor", Ann Otol Rhinol Laryngol, 109(2), pp.204~209 (2000)
36. Hoffman HT, "Vocal process granuloma", Head Neck, 23(12), pp.1061~1074 (2001)
37. Nasri S, "Treatment of vocal fold granuloma using botulinum toxin type A", Laryngoscope, 105(6), pp.585~588 (1995)
38. Yılmaz T, "Botulinum toxin A for treatment of contact granuloma", J Voice, 30(6), pp.741~743 (2016)
39. Orloff LA, "Vocal fold granuloma : successful treatment with botulinum toxin", Otolaryngol Head Neck Surg, 121(4), pp.410~413 (1999)
40. Lee SW, "Comparison of treatment modalities for contact granuloma : a nationwide multicenter study", Laryngoscope, 124(5), pp.1187~1191 (2014)
41. Boyce C, "Management of idiopathic vocal process granuloma : a survey of academic laryngologists", Laryngoscope, 134(2), pp.795~802 (2024)
42. Czesak MA, "Methods of surgical treatment of bilateral vocal fold paralysis", Endokrynol Pol, 71(4), pp.350~358 (2020)
43. Ongkasuwan J, "The role of botulinum toxin in the management of airway compromise due to bilateral vocal fold paralysis", Curr Opin Otolaryngol Head Neck Surg, 19(6), pp.444~448 (2011)
44. Zealear DL, "Electrically stimulated glottal opening combined with adductor muscle botox blockade restores both ventilation and voice in a patient with bilateral laryngeal paralysis", Ann Otol Rhinol Laryngol, 111(6), pp.500~506 (2002)
45. Drobik C, "Frey’s syndrome : treatment with botulinum toxin", Acta Otolaryngol, 115(3), pp.459~461 (1995)
46. Marchese MR, "Not only gustatory sweating and flushing : signs and symptoms associated to the Frey syndrome and the role of botulinum toxin A therapy", Head Neck, 43(3), pp.949~955 (2021)
47. Xie S, "Efficacy and safety of botulinum toxin type A for treatment of Frey’s syndrome : evidence from 22 published articles", Cancer Med, 4(11), pp.1639~1650 (2015)
48. Beerens AJ, "Botulinum toxin A in the treatment of patients with Frey syndrome", Br J Surg, 89(1), pp.116~119 (2002)
49. Hartl DM, "Botulinum toxin A for quality of life improvement in post-parotidectomy gustatory sweating(Frey’s syndrome)", J Laryngol Otol, 122(10), pp.1100~1104 (2008)
50. Lee YC, "Prevalence and risk factors of sialocele formation after partial superficial parotidectomy : a multi-institutional analysis of 357 consecutive patients", Head Neck, 38(Suppl 1), pp.E941~E944 (2016)
51. Vargas H, "A pilot study evaluating the treatment of postparotidectomy sialoceles with botulinum toxin type A", Arch Otolaryngol Head Neck Surg, 126(3), pp.421~424 (2000)
52. Lee DJ, "Intraoperative botulinum toxin injection for superficial partial parotidectomy : a prospective pilot study", Clin Otolaryngol, 46(5), pp.998~1004 (2021)
53. Laskawi R, "Botulinum toxin treatment of salivary fistulas following parotidectomy : follow-up results", Oral Maxillofac Surg, 17(4), pp.281~285 (2013)
54. Maharaj S, "Botulinum toxin A is an effective therapeutic tool for the management of parotid sialocele and fistula : a systematic review", Laryngoscope Investig Otolaryngol, 5(1), pp.37~45 (2020)
55. Mazlan M, "A double-blind randomized controlled trial investigating the most efficacious dose of botulinum toxin-A for sialorrhea treatment in Asian adults with neurological diseases", Toxins(Basel), 7(9), pp.3758~3770 (2015)
56. Heikel T, "Botulinum toxin A in the management of pediatric sialorrhea : a systematic review", Ann Otol Rhinol Laryngol, 132(2), pp.200~206 (2023)
57. Gonzalez-L MD, "Factors in the efficacy, safety, and impact on quality of life for treatment of drooling with botulinum toxin type A in patients with cerebral palsy", Am J Phys Med Rehabil, 96(2), pp.68~76 (2017)
58. Wu KP, "Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study", J Child Neurol, 26(7), pp.838~843 (2011)
59. Chinnapongse R, "Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson’s disease : a prospective double-blind trial", Mov Disord, 27(2), pp.219~226 (2012)
60. Gillespie MB, "Clinical and quality-of-life outcomes following gland-preserving surgery for chronic sialadenitis", Laryngoscope, 125(6), pp.1340~1344 (2015)
61. Kwon SY, "Botulinum toxin injection for chronic parotitis : a multi-center and prospective trial", Laryngoscope, 131(6), pp.E1903~E1909 (2021)
62. Nieri CA, "Botox for the prevention of radiation-induced sialadenitis and xerostomia in head and neck cancer patients : a pilot study", Head Neck, 45(9), pp.2198~2206 (2023)
63. Netterville JL, "Vagal paraganglioma : a review of 46 patients treated during a 20-year period", Arch Otolaryngol Head Neck Surg, 124(10), pp.1133~1140 (1998)
64. Cohen SM, "Surgical management of parapharyngeal space masses", Head Neck, 27(8), pp.669~675 (2005)
65. Lee BJ, "Novel treatment of first bite syndrome using botulinum toxin type A", Head Neck, 31(8), pp.989~993 (2009)
66. Steel SJ, "First bite syndrome : what neurologists need to know", Curr Pain Headache Rep, 25(5), pp.31~ (2021)
67. Abdel Jalil AA, "Approach to the patient with dysphagia", Am J Med, 128(10), pp.1138~ (2015)
68. Kuhn MA, "Management of cricopharyngeus muscle dysfunction", Otolaryngol Clin North Am, 46(6), pp.1087~1099 (2013)
69. Schneider I, "Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin:introduction of a new, noninvasive method", Ann Otol Rhinol Laryngol, 103(1), pp.31~35 (1994)
70. Kocdor P, "Cricopharyngeal dysfunction: a systematic review comparing outcomes of dilatation, botulinum toxin injection, and myotomy", Laryngoscope, 126(1), pp.135~141 (2016)
71. Moerman MB, "Cricopharyngeal botox injection : indications and technique", Curr Opin Otolaryngol Head Neck Surg, 14(6), pp.431~436 (2006)

관련 논문AI추천